U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.313G>A (p.Gly105Ser) AND Li-Fraumeni syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 15, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001379190.10

Allele description [Variation Report for NM_000546.6(TP53):c.313G>A (p.Gly105Ser)]

NM_000546.6(TP53):c.313G>A (p.Gly105Ser)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.313G>A (p.Gly105Ser)
HGVS:
  • NC_000017.11:g.7676056C>T
  • NG_017013.2:g.16495G>A
  • NM_000546.6:c.313G>AMANE SELECT
  • NM_001126112.3:c.313G>A
  • NM_001126113.3:c.313G>A
  • NM_001126114.3:c.313G>A
  • NM_001126118.2:c.196G>A
  • NM_001276695.3:c.196G>A
  • NM_001276696.3:c.196G>A
  • NM_001276760.3:c.196G>A
  • NM_001276761.3:c.196G>A
  • NP_000537.3:p.Gly105Ser
  • NP_001119584.1:p.Gly105Ser
  • NP_001119585.1:p.Gly105Ser
  • NP_001119586.1:p.Gly105Ser
  • NP_001119590.1:p.Gly66Ser
  • NP_001263624.1:p.Gly66Ser
  • NP_001263625.1:p.Gly66Ser
  • NP_001263689.1:p.Gly66Ser
  • NP_001263690.1:p.Gly66Ser
  • LRG_321:g.16495G>A
  • NC_000017.10:g.7579374C>T
  • NM_000546.4:c.313G>A
  • NM_001276760.2:c.196G>A
Protein change:
G105S
Links:
dbSNP: rs1060501195
Molecular consequence:
  • NM_000546.6:c.313G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.313G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.313G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.313G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.196G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.196G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.196G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.196G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.196G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Li-Fraumeni syndrome (LFS)
Synonyms:
Sarcoma family syndrome of Li and Fraumeni
Identifiers:
MONDO: MONDO:0018875; MedGen: C0085390; OMIM: PS151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001576941Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 15, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A quantitative model to predict pathogenicity of missense variants in the TP53 gene.

Fortuno C, Cipponi A, Ballinger ML, Tavtigian SV, Olivier M, Ruparel V, Haupt Y, Haupt S, Study ISK, Tucker K, Spurdle AB, Thomas DM, James PA.

Hum Mutat. 2019 Jun;40(6):788-800. doi: 10.1002/humu.23739. Epub 2019 Mar 18.

PubMed [citation]
PMID:
30840781

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. Epub 2003 Jun 25.

PubMed [citation]
PMID:
12826609
PMCID:
PMC166245
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001576941.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 105 of the TP53 protein (p.Gly105Ser). This missense change has been observed in individuals with clinical features of Li-Fraumeni syndrome (Invitae; external communications). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly105 amino acid residue in TP53. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12826609; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on TP53 function (PMID: 12826609, 29979965, 30224644, 30840781). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 12826609, 29979965, 30224644) indicates that this missense variant is expected to disrupt TP53 function. ClinVar contains an entry for this variant (Variation ID: 428884).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 12, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search